CMT Research Foundation

05/11/2026

By the end of the three-year project, the team expects to have both a validated lead therapy for CMT2A and a suite of reliable biomarkers to measure its effect. Learn more about how through the link!

Read "New Study at UC San Diego Aims to Identify Best Genetic Treatment for CMT2A", and other CMTRF Funded Research articles from the CMT Research Foundation.

04/29/2026

Join us in celebrating this breakthrough FDA approval led by Dr. Meghan Drummond, now CMTRF's Vice President of Research and Drug Development!

The newly-approved treatment restores hearing in children born deaf due to a mutation in a single gene. The lessons learned can apply directly to CMT research.

Read "Her Last Genetic Medicine Earned FDA Approval; Now She’s Leading the Way on CMT", and other Drug Development, Research News articles from the CMT Research Foundation.

04/24/2026

Our GENE THERAPIES DEMYSTIFIED series starts May 7; sign up at cmtrf.org/webinars and bring your questions!

04/22/2026

“Programs like LeadersLink give us the rare opportunity to learn from organizations that have already blazed this path – deepening our capacity to be the strategic, high-impact partner the CMT community deserves.” - Laura MacNeil, CEO CMTRF

Read "CMTRF CEO Welcomed to Prestigious Cohort of Non-profit Research Leaders", and other Uncategorized articles from the CMT Research Foundation.

04/16/2026

REGISTER: Join us on May 7 to learn more about gene therapies and CMT. Bring your questions!

Read "WEBINAR: Gene Therapies Demystified, Understanding the Fundamentals for CMT", and other CMT Research Updates, Foundation News articles from the CMT Research Foundation.

04/07/2026

You could win Alan Jackson's Corvette!

Share this raffle with your networks. It offers incredible prizes and benefits CMT research.

Read "Alan Jackson Raffle Offers Exclusive Prizes, Benefits CMT Research Foundation", and other Foundation News articles from the CMT Research Foundation.

04/01/2026

WATCH: Dr. Wolfgang Pernice explains his project to use AI for detecting subtle movement differences in CMT.

This could go a long way toward improving clinical trials for CMT drugs, where results can be difficult to measure.

Dr. Wolfgang Pernice of Columbia University presents on DANCER (Digital Assessment of Natural Motion for Clinical Endpoint Research), his project to better u...

03/27/2026

NEW PROJECT: The CMT Research Foundation has funded a new study at Johns Hopkins University to find a blood-based biomarker that could measure whether future CMT treatments are working. The research is led by Dr. Jeremy Sullivan and Dr. Charlotte Sumner.

Read "CMTRF Funds Project to Measure if CMT Treatment is Working", and other CMT Research Updates, CMTRF Funded Research, Research News articles from the CMT Research Foundation.

03/23/2026

Join us on Thursday for this unique webinar on using AI to track CMT progression as a way of advancing research.

Read "Using AI to Our Advantage: A Breakthrough Tool for Tracking CMT Progression", and other CMTRF Funded Research articles from the CMT Research Foundation.

03/18/2026

A new CMT drug was administered in a Phase 1 clinical trial in China, and there’s already a path cleared for bringing it to the United States.

Read "New CMT Drug Enters Human Trials in China", and other CMT Research Updates, Research News articles from the CMT Research Foundation.